Nature Biotechnology, Published online: 28 July 2026; doi:10.1038/s41587-026-03264-4
The new laws break away from 20-year-old restrictive GMO directives to give an official nod to plants made with new genomic techniques.
Nature Biotechnology, Published online: 28 July 2026; doi:10.1038/s41587-026-03264-4
The new laws break away from 20-year-old restrictive GMO directives to give an official nod to plants made with new genomic techniques.
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology.
When it comes to organ donation, time is everything. As soon as an organ has been removed from a donor’s body, it starts to deteriorate. Surgeons have only a matter of hours to get it into a recipient.
In most cases, organs will be kept on ice during that time, at around 4 °C (39 °F). They cannot be frozen—in previous attempts, ice has formed, causing all kinds of damage.
But now, scientists have come up with a device that allows organs to be cooled to -4 °C (25 °F) without forming any ice. They’ve tested it with pig organs and shown that kidneys, at least, can be preserved in the device for days then successfully transplanted.
—Jessica Hamzelou
If you want to read more about this story and its implications for organ preservation and transplantation, sign up to receive The Checkup, our weekly biotech newsletter, later today.
The must-reads
I’ve combed the internet to find you today’s most fun/important/scary/fascinating stories about technology.
1 Inside China’s epic push to replace US chips
The gap between their chips’ capabilities remains large—for now. (WSJ $)
+ How China is using open source AI as a new form of soft power around the globe. (NYT $)
+ A new bill in the US takes aim at Chinese AI companies’ training practices. (NBC)
+ US lawmakers are also mulling banning the military from using Chinese humanoid robots. (SCMP)
2 Space data centers don’t exist yet, but people already oppose them
Environmental experts warn it’ll further pollute the stratosphere. (Guardian)
+ Four things we’d need to put data centers in space. (MIT Technology Review)
+ What it’s like inside the data centers powering AI down here on Earth. (Axios)
+ The left and right are finding common cause with data center protests in the US. (The Verge)
3 US lawmakers are pushing for an AI ‘kill switch’
After OpenAI’s models went rogue and hacked Hugging Face. (BBC)
4 Peptides seem on the cusp of going mainstream in the US
A lack of scientific evidence didn’t stop the FDA just voting to let some pharmacies to legally dispense them. (Wired $)
+ How does Make America Healthy Again hold up to scientific scrutiny? (Nature)
+ US measles cases are reaching levels not seen for three decades. (Wired $)
+ Peptides are everywhere. Here’s what you need to know. (MIT Technology Review)
5 The EU just fined Google almost $1 billion
For competition breaches over apps and search. (FT $)
+ It came just a day before Trump renewed tariffs on 60 trading partners, including the EU. (BBC)
6 Electric vehicles are selling well in Europe
And the share made by Chinese firms has doubled in the last year. (The Next Web)
+ Hybrids are hot property in the US this summer. (Wired $)
7 There’s a worsening shortage of computer science professors
You can blame AI companies—they keep snapping them up, to our general detriment. (The Atlantic $)
8 A judge caught a stenographer allowing AI errors into their transcript
It’s apparently the first time this has happened, but it certainly won’t be the last. (404 Media)
+ Even judges themselves are falling for AI. (MIT Technology Review)
9 Here’s what new tech millionaires will do with their IPO wealth 
What a nice problem to have to grapple with! (Quartz $)
10 Dating apps’ latest wheeze? In-person events
Well well well, it seems we’ve come full circle. (Bloomberg $)
Quote of the day
—The voiceover from a new advert from Meta, which exhorts us to be more optimistic about AI.
One More Thing
AI is changing how we study bird migration
In a warming world increasingly full of human infrastructure that can be deadly to them, like glass skyscrapers and power lines, migratory birds are facing many existential threats.
Scientists rely on a combination of methods to track the timing and location of their migrations, though each has shortcomings. But now, machine-learning tools are unlocking a treasure trove of acoustic data for ecologists.
—Christian Elliott
We can still have nice things
A place for comfort, fun, and distraction to brighten up your day. (Got any ideas? Drop me a line.)
+ It’s never too late to live your dreams. Here’s how these late bloomers did it.
+ Limbs feeling a bit tight? Try these stretches!
+ These English football fans went to the 1986 World Cup—and loved it so much they never came home.
+ How the invention of the humble paint tube revolutionized the world of art.
In a boost for greater clinical trial transparency, the European Medicines Agency (EMA) is taking what consumer advocacy groups are calling unexpectedly “rapid action” to ensure that study results are made public as required by law.
The move comes after a recent analysis found results for less than half of the studies registered in a key European database were reported within the required time frame and complete results were fully reported for only 42%. The researchers contended that overall compliance with legal reporting requirements was weak and regulatory oversight is lacking.
This was the first analysis to examine the Clinical Trial Information System (CTIS) that was created in 2022 as part of an effort to enhance transparency across the European Union and the European Economic Area. The registry contains more than 8,400 mid- and late-stage trials and, in the coming months and years, sponsors will be legally required to make results public.
Manufacturers of cell-containing products are adopting new techniques to work around unclear regulatory guidance on particulates. That’s the experience of Diana Colleluori, PhD, principal chemistry, manufacturing and controls (CMC) consultant at Biologics Consulting.
According to Colleluori, cell-containing products can be harder to visually inspect for particulates, as they’re not clear and are often stored in opaque bags.
“Processing and testing cell-containing products already has challenges because they can’t be terminally sterilized,” she explains. “It’s also harder to make a visual assessment to meet regulatory requirements because they already contain cells and the final product is usually in a cell-freezing bag.”
The particulates are mostly (90%) plastic that enter the product from contact with the inside of single-use equipment used during manufacturing, she says, adding that other particulates can enter from product manipulation and, thus, it’s best to try to minimize this.
Companies that Colleluori has worked with have tackled this problem by running their process with the formulation buffer, but minus cells, she continues. This allows them to assess particulates in a clear solution, outside of a bag, which they can then extrapolate to running the same process with cells.
“By testing visible and sub-visible particles in those samples, you can prove your product contact materials are expected to meet the limits for your cell-containing products,” according to Colleluori.
The company can also run quality control tests on a small sample of the final product. Among the tests carried out are those based on the United States Pharmacopeia (USP) chapters 790 for visible particulates and injections,1790 for visual inspections of injections, and 788 for the sub-visible particles.
In addition, EU guidance on visual inspection of particles can also be relied upon. Which tests are run should depend on the method of administration, adds Colleluori.
“If you’re doing an intramuscular injection, it’s probably a little less rigorous than an intrathecal injection of products that have stricter regulations on the number of particles and sub-particles that can be present,” she says.
The post Cell-Therapy Manufacturers Get Creative on Checking Particulates appeared first on GEN – Genetic Engineering and Biotechnology News.
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology.
Last weekend, several current and former advisers to President Donald Trump on AI publicly lobbed insults at the country’s leading AI companies. David Sacks branded Anthropic’s models “lobotomized” and “woke.” Emil Michael, a top Pentagon official, called OpenAI’s new head of strategic futures a “supreme village idiot.”
It began because no one can agree on what to do about Kimi, a free, open-source model that Chinese AI company Moonshot launched last week. It appears to rival the intelligence of models from OpenAI and Anthropic, which are very much not free.
Every time a new smart, free model from China gets released, US companies see less reason to fork out money for models from Anthropic or OpenAI. That’s creating economic and political problems for the president—and dividing the top AI strategists in his orbit.
Read the full story on why no one can agree what to do about Kimi.
—James O’Donnell
This article is from The Algorithm, our weekly AI newsletter. Sign up to receive it in your inbox every Monday.
The must-reads
I’ve combed the internet to find you today’s most fun/important/scary/fascinating stories about technology.
1 Anthropic’s record $1.5 billion copyright settlement has been approved
The plaintiffs said Anthropic used pirated works to train Claude. (Reuters $)
+ And won the largest known copyright payout in history. (Engadget)
+ Yet many authors and creators still don’t view it as a win. (TechCrunch)
+ But AI copyright anxiety could limit creativity. (MIT Technology Review)
2 The Trump administration is weighing a ban on Chinese AI models
The launch of Kimi K3 has revived calls for restrictions. (Axios)
+ But officials are divided on the proposals. (Fast Company)
+ China’s bet on open-source is paying off. (MIT Technology Review)
3 China is mulling tighter export controls on AI models and chips
It wants to stop the West from acquiring its tech and startups. (FT $)
+ Beijing has held talks with tech firms about potential restrictions. (Reuters $)
4 Trump’s AI safety head has resigned after just three months
Chris Fall had led CAISI, the federal AI Safety Institute, since April. (Axios)
+ No reason was given for his exit. (CNBC)
5 Google is working on a new chip to run Gemini models more efficiently
The chip, called “Frozen V2,” may be deployed in 2028. (Information $)
+ Alphabet stock popped on the report. (CNBC)
6 New Orleans police have explored arming drones with weapons
A draft drone manual paves the way for weaponised quadcopters. (404 Media)
+ Shoplifters could soon be chased by drones. (MIT Technology Review)
7 The EU has handed AliExpress a record fine over unsafe product sales
The €550 million fine is the largest-ever under the Digital Services Act. (BBC)
+ Alibaba has vowed to appeal the fine. (SCMP)
8 Election advice from AI chatbots is “inaccurate and unreliable”
That’s the conclusion from tests in Hungary earlier this year. (Guardian)
9 Red light therapy is showing promise for healing and healthy aging
Better skin and reduced vision loss are also on the cards. (Economist $)
10 Neill Blomkamp’s new horror clip is all AI-generated—and it sucks
The acclaimed director wants to make “a full feature in this format.” (Gizmodo)
Quote of the day
—Tech investor Chamath Palihapitiya slams plans to restrict Chinese AI models in a post on X.
One More Thing
Early on the morning of September 2, 2024, four people were shot and killed on a westbound train in Chicago. Police swiftly activated a digital dragnet—a surveillance network that connects thousands of cameras across the city—and arrested the suspect just 90 minutes later.
Law enforcement and security advocates say this vast monitoring system protects public safety and works well. But activists and many residents say it’s a surveillance panopticon that creates a chilling effect on behavior and violates guarantees of privacy and free speech.
Go inside the surveillance network that’s dividing Chicago.
—Rod McCullom
We can still have nice things
A place for comfort, fun, and distraction to brighten up your day. (Got any ideas? Drop me a line.)
+ NASA has shared a stunning timelapse video of the Psyche spacecraft’s view of Mars.
+ This comparison of American and European Urbanism shows good city design is a choice.
+ Musician Luca Stricagnoli recently performed a marvellous acoustic guitar medley of Prodigy songs.
+ Two Australian paddleboarders saved a stranded wallaby after it was swept out to sea—and caught the whole rescue on video.
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology.
Perimenopause used to be considered taboo, but not anymore. Thanks at least in part to TV doctors and social media influencers, conversations about the sometimes years-long period before menopause are now more open than ever. But the conversation is increasingly shaped by misinformation.
Despite what some marketers will claim, there is no test for perimenopause. That doesn’t mean women should have to put up with symptoms, but treatment suggestions often lack scientific evidence. And not all the symptoms women experience in midlife can be blamed on hormones.
Read the full story on the hype and misinformation surrounding perimenopause.
—Jessica Hamzelou
This article is from The Spark, our weekly climate tech newsletter. Sign up to receive it in your inbox every Wednesday.
The must-reads
I’ve combed the internet to find you today’s most fun/important/scary/fascinating stories about technology.
1 China’s AI gap with the US may have just narrowed
A Chinese startup has released the world’s largest open AI model. (Reuters $)
+ It competes with some Anthropic and OpenAI models. (Gizmodo)
+ The model’s launch sent AI and semiconductor stocks sliding. (Bloomberg $)
+ Chinese Nvidia alternatives are also gaining traction. (SCMP)
+ Xi Jinping pitched China as an AI partner to the developing world. (CNBC)
+ The country is betting big on open-source. (MIT Technology Review)
2 Trump Media is selling instant access to “market-moving’ social posts
It’s developed a new way to monetize the president’s posts. (Quartz)
+ And Trump could profit directly from selling access to his statements. (BBC)
+ Kalshi says it caught Trump’s teleprompter operator insider trading. (Verge)
3 Astronomers have found an atmosphere on a nearby Earth-like planet
It’s the first potentially habitable world known to host an atmosphere. (NYT $)
+ Making it a top contender in the search for aliens. (404 Media)
+ But you need to know how to spot one. (MIT Technology Review)
4 A brain implant has restored feeling in a paralysed hand
The recipient can now feed himself and drink from a cup. (Guardian)
+ Movement continued when the stimulation was turned off. (New Scientist $)
+ China has approved a world-first brain chip. (MIT Technology Review)
5 The EU has told Google to share search data and open up AI on Android
It will be forced to share data with competing search providers. (Ars Technica)
+ And open Android phones to rivals’ AI bots. (WP $)
6 Period trackers are hiding privacy problems
New research uncovers how they’re sharing users’ health data. (BBC)
7 The Tesla driver in a fatal Texas crash overrode FSD, investigators say
He bypassed the tech by pressing the gas pedal to 100%. (Verge)
8 A new stealth drone spins so fast that it disappears
Though its creators admit it can still be easily heard. (New Scientist $)
9 A space-station study suggests why astronauts’ bodies waste away
Microgravity disrupts mitochondria, reducing protein production. (Nature)
10 “Adversarial clothing” that confuses facial recognition is all the rage
Privacy could be the next big trend. (Guardian)
Quote of the day
—George Chen, chair in digital practice at The Asia Group consultancy, gives Reuters his take on Xi Jinping’s speech at the World Artificial Intelligence Conference (WAIC) in Shanghai.
One More Thing
A new industrial facility in suburban Seattle is giving off a whiff of futuristic technology. It can safely treat fecal waste from people and livestock while recycling nutrients that are crucial for agriculture but in increasingly short supply across the nation’s farmlands.
It’s among a range of systems reframing feces, urine, and their ingredients as invaluable natural resources to reuse instead of waste products to burn or bury. Several companies are now showing how to safely scale up the transformation with energy-efficient technologies.
Find out how human waste is being transfomed into agricultural solutions.
—Bryn Nelson
We can still have nice things
A place for comfort, fun, and distraction to brighten up your day. (Got any ideas? Drop me a line.)
+ Soccer icons have received the Ghanaian movie poster treatment.
+ A captivating cosmic construction project is July’s Picture of the Month from the James Webb Space Telescope.
+ Sir David Attenborough recently turned 100. Here’s everything he’s ever worked on, all in one place.
+ “Desire paths” are the trails made by people walking contrary to defined routes. This video explains what they mean about psychology and design.
Every morning, airline dispatchers, grid operators, and farmers around the world make decisions based on the same thing: a weather forecast.
While these forecasts are something that most people glance at for two seconds, weather predictions influence major strategic decisions in many industries, with real money, livelihoods, and even actual lives at stake. Farmers use them to determine which crop variety to sow, when to fertilize, how much to invest in irrigation infrastructure, and how long livestock should graze. Utilities use them to decide where to build solar and wind farms, as well as how to price wholesale electricity. Predictions are used to warn people about extreme weather and to trigger emergency response measures. More recently, weather predictions have become relevant for an emerging industry: prediction markets, where people bet money on all kinds of real-world events, including the weather.
However, the temptation to manipulate weather data to get an edge in these markets, combined with a collective move toward data-driven AI weather forecasting, is starting to put the accuracy of weather predictions at risk. These risks are relatively manageable for now, but as experts in the field, we can foresee scenarios where they snowball into far bigger, more systemic problems.
To develop weather predictions, we need accurate observations of current conditions. These are collected from several sources, including weather stations at airports, utilities, or transport services. Traditional operational systems like the Weather Research and Forecasting model or the European Centre for Medium-Range Weather Forecast (ECMWF) Integrated Forecasting System combine these observations with numerical approximations in order to estimate future weather patterns.
Sometimes, weather stations have issues because of, for example, instrument failures or upgrades in equipment. These can be caught either in real time (through checking and correction) or retroactively. Traditional forecasting systems also have a built-in safeguard called data assimilation: Every incoming measurement is weighed against what the physical model says should be happening and against readings from nearby stations.
Together, these mechanisms help keep weather observations reliable and predictions robust. However, new threats are putting observational accuracy at risk. Earlier this year, news outlets reported that the weather station at Paris Charles de Gaulle Airport (CDG) had been manipulated to record suspicious temperature spikes on April 6 and April 15, 2026. Authorities speculate that a hand-held hairdryer or lighter might have come into play. Either way, it led to some big payouts for online prediction-market gamblers who had bet it would hit 22 °C (71.6 °F) on days when the actual average was around 18°C (64.4°F). One individual won $20,000.
Fortunately, tampering with a single station like this can usually be caught by human monitoring or current statistical methods. In this case, members of a French climate nonprofit association noticed the anomalies by chance and raised the alarm.
But what if there are no human monitoring systems in place? And what about other types of manipulation? What if, instead of tampering with one station, someone remotely nudged the readings at many stations at once—making each change small enough to look plausible on its own? Existing quality controls struggle to catch this kind of coordinated manipulation. And time works against us; careful checks of data and metadata take hours or days, but forecasts have to go out on schedule, whatever the weather is doing.
The shift toward artificial intelligence in weather prediction raises the stakes. These methods are even more dependent on accurate, reliable weather observations; in fact, they are known as “data-driven models.” For example, researchers at ECMWF are exploring whether high-quality weather forecasts can be produced directly from raw observations, skipping the assimilation step that currently acts as a quality filter. Other researchers are going one step further; combining geospatial data (including weather station data) with large language models and agentic AI to support real-time, autonomous decision-making during extreme events such as storms.
Possible benefits are improvements in accuracy, efficiency, and speed. But removing humans from the equation introduces a vast range of new risks.
At the low end of the risk scale, an individual speculator manipulates a weather station for personal gain—that is the CDG Airport case. One step up: A group of traders could coordinate to bias forecasts of renewable energy output, moving wholesale electricity prices and leaving whoever is on the other side of the trade holding the loss. And at the far end, a state actor or saboteur could manipulate one or many stations to set off an early warning system or even keep one silent when it should sound. Step by step, the risk grows, from fraud to compromised disaster preparedness to a matter of national security.
As long as there are financial (or other) incentives to manipulate observational data, adversaries will search for new opportunities, and it is our task to stay one step ahead. Here are three ways.
1. Watch the stations. Data quality controls should include station security, anomaly detection and correction, and human oversight. Weather stations should be monitored continuously to deter tampering. Data homogenization methods that clean up weather records also need to get faster, with the goal of catching problems in real time. This will become increasingly important as agentic AI systems use these data to deliver real-time decisions. Finally, human oversight is needed to flag questionable data and model outcomes. After all, it was humans who caught the CDG Airport manipulation.
2. Protect the data to safeguard the AI. Data defense mechanisms must be positioned throughout the AI pipeline. AI explainability and adversarial robustness tools can help us understand the underlying data and the AI model outputs, help us identify data- or model-related issues, and potentially make us more resilient to adversarial attacks.
3. Ensure continuous accountability along the chain. Observational data passes through many hands: the operators who run the stations, the national weather services that steward the records, and the forecasting centers that turn them into predictions. No single one of them can protect data integrity alone—each guards its own link, and any anomaly needs to be communicated along the whole chain, from station operators to the people acting on the forecast.
It is fortunate that the situation at CDG Airport was caught, but it should serve as a wake-up call. As the role of observational data grows in weather forecasting, we need to adapt to evolving threats. This means protecting our data and models by strengthening existing oversight and accountability structures, and improving coordination among key partners.
This op-ed was written by:
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology.
Ties van der Meer doesn’t know how many siblings he has. The 47-year-old was conceived at a private fertility clinic using sperm from an anonymous donor. He eventually tracked down one sibling, but he may have others he’ll never find.
Other donor-conceived people have found they have tens or even hundreds of them. “It does make you feel a bit mass-produced,” said one who discovered they had 25 half-siblings.
In response, a European fertility organization says we need international limits on the number of children a single donor can contribute to.
Find out what their proposal could achieve—and where it may fall short.
—Jessica Hamzelou
This story is from The Checkup, our weekly biotech newsletter. Sign up to receive it in your inbox every Thursday.
LLMs have transformed what AI can do with language, but helping machines understand and operate within physical spaces presents a different challenge. In response, researchers are developing a new form of artificial intelligence: world models.
At a LinkedIn Live event tomorrow, MIT Technology Review will explore how this technology could shape the future of robotics and open one of AI’s next major frontiers. Join Will Douglas Heaven, our senior editor for AI, and Sam Sinha, founding AI researcher and head of world models at 1X Technologies, for the conversation on Tuesday, July 14.
Register here to attend the free session at 9:30 PDT, 12:30 PM EDT, and 5:30 PM BST.
The must-reads
I’ve combed the internet to find you today’s most fun/important/scary/fascinating stories about technology.
1 Apple has sued OpenAI for allegedly stealing trade secrets
OpenAI purportedly stole IP to develop its own consumer hardware. (CNBC)
+ The suit claims OpenAI poached Apple staff to access the information. (BBC)
+ And requested trade secrets in job interviews with Apple workers. (Guardian)
+ Apple also sued two former employees, Chang Liu and Tang Tan. (Reuters $)
2 A Nobel-winning chemist is leaving the US to lead an AI lab in China
Omar Yaghi will head an institute using AI to discover new materials. (LA Times $)
+ He won a Nobel Prize in Chemistry for creating “molecular sponges.” (NYT $)
+ His departure comes as China tries to woo US scientists. (Nature)
+ The White House has slashed science spending. (MIT Technology Review)
3 The EU is moving closer to banning children from social media
It’s proposed barring under-13s unless supervised by an adult. (NYT $)
+ And limiting access for older children. (Bloomberg $)
+ The EU has also told Meta to disable autoplay and infinite scroll. (Politico $)
4 Meta scrapped an AI image feature on Instagram after a backlash
It allowed users to generate images based on public accounts. (TechCrunch)
+ And automatically opted in any Instagram user with a public account. (NYT $)
+ AI memories are privacy’s next frontier. (MIT Technology Review)
5 Phoebe Gates’ shopping app claimed credit for sales it didn’t drive
Phia claimed unearned affiliate sales through fake clicks. (Bloomberg $)
+ Cofounder Gates is the daughter of Microsoft cofounder Bill. (Engadget)
6 Leaked police drone footage exposes the new reality of surveillance
Hours of San Francisco Police video were accidentally released. (Wired $)
+ Surveillance from drones is on the rise in the US. (MIT Technology Review)
7 Over two-thirds of Americans back a Sanders-style AI ownership plan
A poll found strong support for public ownership of AI stock. (Gizmodo)
+ Tech firms have their own takes on the idea. (MIT Technology Review)
8 AI may soon make campaign text messages more potent—and irritating
AI platforms are training bots to sound like political candidates. (NPR)
9 An orbiting disco ball gave Einstein’s theory its most precise test yet
It measured Earth’s twisting of space-time more precisely. (Rest of World)
10 Australia’s biggest radio hit may be the product of GenAI
Musicians are questioning how the song was made. (Guardian)
Quote of the day
—A text message sent by former Apple engineer Chang Liu to a colleague, which a new lawsuit alleges was part of a scheme to steal hardware IP for OpenAI.
One More Thing

On a bright April morning in 2025, a surveillance plane operated by the Colombian military spotted a 40-foot-long “narco sub” idling in the Caribbean Sea. The stealthy vessel, used by drug cartels to move cocaine north, could sail with its hull almost entirely underwater.
After seizing the boat, the coast guard noticed something unusual: there was no one on board. This was Colombia’s first confirmed uncrewed narco sub, operable by remote control, but also capable of a degree of autonomous travel.
Uncrewed subs could move more cocaine over longer distances, and they won’t put human smugglers at risk of capture. Find out how they may transform the drug trade.
— Eduardo Echeverri López
We can still have nice things
A place for comfort, fun, and distraction to brighten up your day. (Got any ideas? Drop me a line.)
+ Metallica’s “Enter Sandman” has been reinvented as a yacht rock track.
+ Two super-puff planets lighter than cotton candy have been spotted floating through space.
+ An inventor has given Tic Tac fans (like Donald Trump) a solution to the box’s annoying rattling in their pockets.
+ Imbibe a dose of adrenaline with this first-person footage of a rider on heart-pounding Red Bull Genova Cerro Abajo.
Vertex Pharmaceuticals has agreed to acquire Crinetics Pharmaceuticals for $10 billion cash, the companies said, in a deal that would expand the buyer’s rare disease portfolio beyond its anchor indication of cystic fibrosis (CF), by adding an approved treatment and a pipeline anchored by two Phase III candidates, all predicted to generate more than $5 billion in annual revenue.
Based in San Diego, Crinetics focuses on discovering, developing, and commercializing therapeutics for endocrine diseases. The company’s first marketed drug Palsonify® (paltusotine), an oral SST2 agonist, was approved by the FDA in September as the first and to date only once-daily oral therapy for adults with acromegaly, a debilitating condition which affects an estimated 20,000 Americans. Palsonify won European Commission approval in April and is under review by regulators elsewhere in the world.
Palsonify has enjoyed rapid uptake among acromegaly patients, with Crinetics reporting the drug generated net product revenue of $10.3 million during the first quarter, with 232 patients enrolling for treatment. Approximately 70% of patients treated with Palsonify at the end of Q1 were on reimbursed therapy—reflecting payers increasingly agreeing to cover the treatment, according to the company.
Within the first two quarters of its U.S. launch, Palsonify was prescribed by 263 unique healthcare providers.
Under its generic name paltusotine, the drug is in Phase III study for a second indication of carcinoid syndrome, a rare condition resulting from neuroendocrine tumors.

“Crinetics is an excellent strategic fit for Vertex, with its focus on serious diseases in specialty markets with significant unmet need, well-understood causal human biology, and potentially best-in-class medicines that could deliver transformative benefit to patients,” Reshma Kewalramani, MD, Vertex’s CEO and president, said in a statement. “We believe Vertex can build on the strong momentum of the Palsonify launch by applying our experience in commercializing medicines for rare genetic diseases.”
Crinetics investors agreed, roaring their approval of the pending acquisition as the company’s shares all but doubled in early trading Tuesday, zooming 99% to $83.54 as of 10:28 am ET from yesterday’s closing price of $42.03. Vertex shares dipped 2% to $516.48 from $529.59 at Monday’s closing bell.
Also in late-stage development is Crinetics’ lead pipeline candidate atumelnant, an oral adrenocorticotropic hormone (ACTH) antagonist now under development for congenital adrenal hyperplasia (CAH) and ACTH-dependent Cushing’s syndrome.
In classic CAH, a rare chronic genetic disease with 17,000 addressable patients in the U.S., atumelnant is in a pair of clinical trials. One is a Phase III study in adults with the most common cause of the disease, 21-hydroxylase deficiency (21-OHD). The study’s estimated primary completion date is May 2027 (NCT07144163). The other trial is a Phase II/III study in children ages one to <18, which has an estimated primary completion date of March 2030 (NCT07159841).
Earlier Phase II studies of atumelnant showed that patients treated with the therapy achieved near normalization of excess androgen levels on physiologic replacement doses of glucocorticoids—a therapeutic profile that Crinetics has said positions atumelnant to become the leading treatment for people with CAH.
Atumelnant (formerly CRN04894) is also being developed for ACTH-dependent Cushing’s syndrome, and is under study in a Phase Ib/IIa open-label, multiple-ascending dose exploratory study (NCT05804669) designed to evaluate safety, tolerability, pharmacokinetics (PK), and pharmacodynamic biomarker responses associated with the treatment.
“We are also excited by the significant potential of atumelnant to transform the treatment landscape for CAH, setting a new standard of care where patients do not have to choose between managing their excess adrenal androgens and enduring the side effects of high-dose steroids,” Kewalramani said.
One analyst said a Vertex buyout would be good news for Crinetics.
“This is a solid outcome for CRNX, given stock pressure from the near-term Palsonify launch (generally slow and steady launch but (+) [positive] progress by CRNX so far) and the fact that key Phase III catalyst for CAH isn’t until late 2027/28,” Jefferies equity analyst Dennis Ding wrote today in a research note.
In a regulatory filing yesterday, Crinetix shared an email it sent to employees, stating: “We have always been confident in the ability of Crinetics to achieve our plan and were not actively looking to sell the company when Vertex approached us. However, after careful consideration, our board unanimously determined that the transaction is in the best interests of our shareholders.”
Crinetics’ pipeline of more than 10 disclosed candidates includes:
Vertex said the deal was expected to contribute immediately to revenue growth via the ongoing launch of Palsonify, which the company says has blockbuster (greater than $1 billion in annual sales) potential in acromegaly. Longer term, Vertex says, atumelnant could also generate multiple billions of dollars in CAH, with additional revenue potential in Cushing’s syndrome.

At peak year, Palsonify and atumelnant could deliver more than $5 billion in combined annual revenue, Vertex said, and thus contribute toward its goal of delivering sustained double-digit revenue growth, plus industry leading operating margins. The transaction is expected to add to non-GAAP operating income as of 2029.
Jefferies analyst Ding commented that atumelnant in CAH is expected to generate the largest share of the projected $5 billion, as in $2 billion to $3 billion, plus another $1 billion to $2 billion for Cushing’s syndrome–with the remaining $1 billion to be generated by Palsonify in acromegaly.
Scotiabank analyst Louise Chen told Reuters: “The deal adds a fifth vertical, endocrinology, which helps diversify VRTX’s concentration in CF.”
That concentration has proven lucrative for Vertex: During Q1, CF treatments generated $2.915 billion in total revenues, 98% of the company’s total revenue of $2.987 billion.
Vertex has agreed to acquire all outstanding shares of Crinetics common stock for $85 per share cash, in a deal valued at $8.8 billion net of estimated cash acquired. Vertex said it expects to finance the acquisition using a combination of cash on hand and debt, supported by $4.5 billion of fully committed bridge financing from Bank of America and Morgan Stanley Senior Funding.
Vertex finished the first quarter with cash, cash equivalents, and total marketable securities of $13 billion, up from $12.3 billion as of December 31, 2025. The company attributed the increase primarily due to cash flows from operating activities, partially offset by repurchases of Vertex’s common stock.
The transaction is expected to close in the third quarter subject to customary closing conditions, including receipt of regulatory approvals and approval by Crinetics shareholders.
“Nearly 18 years ago, we founded Crinetics with a clear goal of transforming the lives of patients living with endocrine-related diseases. Today marks a historic milestone as we embark on this next chapter with Vertex,” stated R. Scott Struthers, PhD, Crinetics’ co-founder and CEO. “Vertex’s global infrastructure and commercial footprint will serve to amplify the reach of our science and allow us to maximize the impact of Palsonify, atumelnant and our pipeline.”
The post Vertex Eyes Expansion Beyond Cystic Fibrosis with Planned $10B Crinetics Buyout appeared first on GEN – Genetic Engineering and Biotechnology News.
Anthony Agueda, a third-generation California dairy farmer, pulls a rake through a bed of dark, wet wood chips on his family’s land in Hickman, a tiny town in the state’s agricultural heartland.
He reaches down with both hands and pulls up a clump of muck, turning it over to reveal a half-dozen squirming red earthworms. There are likely hundreds of thousands more wriggling just under the surface of the three-foot mound of wood and crushed river rock before us, which stretches across the equivalent of six football fields. These natural materials form a biofilter that may dramatically cut the methane, nitrous oxide, and water pollution generated by the massive amounts of manure that hundreds of Holstein cows produce each day.
Agueda’s family business, the Alberto Dairy, was one of the first cattle operations in California to adopt this approach to manure treatment, developed and patented by the Chilean company BioFiltro. Eight more of these so-called vermifiltration systems are already operating on US dairies, according to the company, while another 16 are under construction or set to be next year, nearly all of them in California.
Vermifiltration is just one of a variety of methods that farmers, companies, and scientists are employing to drive down manure pollution as the livestock industry faces growing pressure to address the environmental harms from one of the smelliest parts of the business. California, easily the nation’s largest milk producer, has established a handful of programs to promote their adoption, including one initiative that has funneled more than a billion dollars to farms.
Researchers stress that much more work needs to be done to determine the most effective approaches, the trade-offs between them, and their success over the long term, under actual farm conditions.
Agueda says that he and his family recognized the need to adopt new practices as environmental rules tightened. They were drawn to vermifiltration because it’s simple and relatively cheap compared with other, higher-tech options.
“California daily farmers are constantly facing more and more regulation,” says Agueda, standing alongside one of the farm’s free-stall barns. “This makes me excited, because it shows how we are part of the solution.”
Manure is responsible for a significant portion of the climate pollution from livestock operations. The World Resources Institute estimates that manure management on dairy and swine farms accounts for 1.6% of the US’s greenhouse-gas emissions. Globally, manure storage and processing makes up about 10% of the livestock industry’s contributions to climate change.
“Farms have become larger in the past two decades or so, so there’s much more manure—and that has to be stored somewhere,” says Swati Hegde, the organization’s global manager of agricultural methane.
Typically, cattle and swine farms spray manure into lagoons or tanks, creating a foul-smelling, low-oxygen slurry in which microorganisms known as methanogens thrive. They gobble up hydrogen, carbon dioxide, and other compounds and produce methane as a by-product. Other microbes in the mix produce smaller amounts of nitrous oxide.

Both are particularly potent greenhouse gases, with as much as 30 to nearly 275 times the warming power of carbon dioxide, respectively, over a century.
The slurry is often spread onto fields to add nutrients to the soil. When it’s done excessively or improperly, this part of the practice can pollute soil or groundwater with drug residues, pathogens like salmonella and E. coli, and nitrates. Nitrates that leach into drinking water have been linked to a variety of human health risks. And those that flow into rivers, lakes, and coastal waters can spawn algae blooms that poison fish, block sunlight, suck up oxygen, or form large coastal dead zones devoid of marine life.
A number of regions, nations, and states have passed regulations or offered subsidies designed to limit the pollution from livestock manure, but so far, most of the major initiatives have focused on water contamination rather than greenhouse-gas emissions.
The European Union, for instance, restricts the amount of manure that farmers can apply to fields and requires member nations to monitor nitrate levels in ground and surface water. The US’s Clean Water Act requires large livestock operations to obtain permits and develop manure management plans that limit pollution.
But California has arguably done the most to use government policy specifically to drive down the methane emissions from livestock. The dairy industry accounts for about 45% of the state’s pollution from the potent greenhouse gas, and more than half of that comes from manure, according to the government’s estimates.
In 2016, the state enacted a law that requires dairies, landfills, and other businesses to cut methane emissions 40% below 2013 levels by 2030, as part of a broader effort to reduce pollution from powerful but short-lived greenhouse gases. The measure directed the California Air Resources Board, the state’s main climate regulatory agency, to set up various incentive programs to encourage these industries to shift to cleaner practices.
“In terms of bang for your buck, short-term benefits, methane can go a long way toward reaching climate goals,” says Tawny Mata, director of California’s Office of Agricultural Resilience and Sustainability.
Between these various programs—and falling livestock numbers in the state—the dairy sector is on track to reduce annual methane emissions by the equivalent of 5 million metric tons of carbon dioxide by 2030, the state estimates. That would still fall about 4 million tons short of the target under the 2016 law.
Excluding the decline in herd populations—which has been driven by growing international competition and rising costs—the vast majority of California’s estimated methane reductions come from the use of what are known as anaerobic digesters. This technology entails covering the slurry lagoons to prevent methane from leaking into the air and then piping the biogas into separate vessels, where it’s cleaned and converted into natural gas.
Under California’s Low Carbon Fuel Standard program, dairies that use digesters to produce gas delivered into pipelines can earn credits and sell them to petroleum refineries and other major polluters, as a means of helping those companies meet their own emissions reduction requirements.
The gas can then fuel power plants, produce hydrogen, or power natural-gas vehicles. These uses still release carbon dioxide, but the state considers it a climate win because it avoids the release of methane, which traps even more heat.
The rich revenue stream from California’s program has spurred hundreds of US farms to install anaerobic digesters over the last decade. Since 2020, it has produced more than $1 billion for farms, Cal Poly researchers noted in a paper last year.
But there are a variety of concerns about this approach.
The first is that it’s viable only for farms with about 2,000 cattle or more, because the equipment is very expensive to install, says Frank Mitloehner, a professor and chair of the Department of Animal Science at the University of California, Davis.
“For the lion’s share of dairies, digesters will not be a solution,” he says.
Since the manure is often still spread across fields, digesters also do little to address the water pollution problems—and can even exacerbate them because of some of the chemistry that occurs during that process.
Yet the huge subsidies flowing to digesters have steered money, energy, and attention away from other solutions that may offer better overall environmental outcomes, says Danny Cullenward, a senior fellow with the Kleinman Center for Energy Policy at the University of Pennsylvania, who has closely studied the California program.
“That is really not a solution at scale, and it’s diverting a huge fraction of precious resources to what I think is mostly not the right answer,” he says.
The high up-front costs and limitations of digesters have spawned growing interest in alternative solutions—many of which work by reducing the formation of methane in the first place instead of turning that methane into a sellable fuel.
One of the cheapest, easiest, and most popular approaches, known as solid separation, uses simple machinery like a screw press to squeeze much of the water out of the manure slurry. The remaining solids are dry and exposed to open air, shifting away from the oxygen-free conditions in which methane is readily produced.
Other methods include increasing acidity in lagoons, bubbling air through them, or adding methane-eating microbes to the slurry, all of which alter the chemistry in ways that promise to reduce the amount of methane released. One company, Sedron Technologies of Sedro-Woolley, Washington, has also developed a sort of high-tech solid separation approach that extracts several marketable products from the animal waste, including a liquid organic fertilizer.
The state of California set up a pair of additional programs to help smaller farmers adopt some of these other approaches, dubbed the Alternative Manure Management Program and the Dairy Plus Program.
The bulk of the funds have gone to solid separation systems. But the state has provided more than $18 million to support 15 vermifiltration projects. The Alberto Dairy has received nearly $2 million between the two programs.
As I drove down a dusty road bordering the dairy, black-and-white bovines, affectionately known as Oreo cows, stretched their heads through the rails of an open barn, nibbling on golden silage scattered along the structure. Agueda’s grandfather Antonio Alberto founded the dairy 45 years ago in nearby Atwater, California, but eventually settled in Hickman, population 604, in 1989.

It was mid-March but already above 80 °F in the Central Valley, which is walled off from the cool Pacific air by the coastal mountain range. Knee-high oat stalks swayed in fields that stretched to a line of almond trees in the distance.
Agueda, who graduated from Fresno State last year and now helps lead the operations on the farm, met me and UC Davis’s Mitloehner, who has studied the effects of vermifiltration, along the side of the barn. (UC Davis has no affiliation with the farm, but the university helped facilitate the meeting.)
He led us along dirt lanes as he explained the workings of the vermifiltration system, which they began using in October 2024.
As before, a flush system washes manure from the floors of the barns into a large collection pit. But now a set of pumps funnels it through a series of large V-shaped metal contraptions standing on a nearby concrete pad, where mechanical screens separate most of the solids from the water.
A conveyor belt takes away the solids, which the farm composts for cow bedding or fertilizer. The remaining liquid moves through a system of pipes, first to settling ponds and then on to an irrigation system suspended above the vermifiltration beds. The long, tubular structure runs over the mounds on wheels set in gravel tracks, wetting the wood chips as it goes. The worms and various microbes residing in the biofilter then set to work consuming much of the remaining solid material, according to BioFiltro.

“Once the water is sprinkled on top, it takes about four hours from beginning to end for it to percolate through and drain to the end,” Agueda says.
He then defers to Mitloehner to explain the science of what happens as it does, adding, “I’m just the dairyman.”
Mitloehner says he was skeptical of BioFiltro’s claims when he first heard them, particularly the assertion that the system could nearly eliminate nitrogen and, with it, the various forms of pollution it can produce, including ammonia and nitrates.
So he decided to study a similar setup at the Fanelli Dairy, an operation in Hilmar, California, about 20 miles to the south. He and colleagues monitored the emissions from wastewater samples that were taken from the system before and after the liquid moved through the filter. In a paper published in 2018, the researchers concluded that vermifiltration reduced ammonia emissions from the resulting water by about 90%.
BioFiltro, whose tagline is “worm-powered solutions,” states that its technology “catalyzes the digestive power of worms and microbes to remove up to 99% of wastewater contaminants.”
But Mitloehner questions how big a role the invertebrates play in the process, calling it “kind of a catchy narrative.”
His take is simpler: The rocks and wood chips form a porous filter that replaces the anaerobic environment of a manure lagoon with an aerobic one. And in that oxygen-rich environment, different types of microbes thrive.
His study suggests that these microbes are highly effective at converting nitrogen compounds in manure into nitrogen gas—a benign gas that makes up 78% of Earth’s atmosphere—instead of ammonia. That’s notable because while ammonia in manure acts as a fertilizer when it’s applied to fields, it also converts into the nitrates that can leach into groundwater.
Several more recent studies, which were partially or fully funded by BioFiltro and one of its regional distribution partners, Organix, produced similarly promising results. For instance, a 2022 study in Bioresource Technology Reports, also conducted at the Fanelli Dairy, concluded that the filter removed nearly 85% of the nitrogen in the operation’s wastewater.
But a befuddling wrinkle is that when it came to methane, those studies and Mitloehner’s independent one found nearly opposite results.
While both the company- and partner-supported studies concluded that the filter eliminated the vast majority of methane pollution, Mitloehner’s study found that methane emissions were nearly 85% higher than those from the lagoon.
In a follow-up email exchange, Mitloehner stressed that it’s not appropriate to compare his results with those that emerged from the other study at the same dairy, because the teams used very different methods, instruments, and measurement periods. Moreover, the focus of his research was the effect on nitrogen.

He said it’s “entirely reasonable” and “biologically plausible” that vermifiltration could substantially reduce methane emissions, simply by creating that aerobic environment.
“That said, I would be cautious about calling the magnitude of the reduction a fully settled issue,” he added. “While the available studies, including those you mentioned, point in the same general direction, the number of independent studies remains relatively limited, and results can vary.”
Patrick Beckett, BioFiltro’s vice president of quality and R&D, also stressed that there were crucial differences in the methodology of Mitloehner’s study that could have affected his methane findings.
In addition, he said the Organix funding came by way of a Washington state grant and described that study and the one BioFiltro supported as “high quality, peer reviewed” research that “has been submitted to other technical third parties for review and acceptance.”
Beckett says he agrees that additional independent reviews of BioFiltro’s systems is “fair and necessary” and notes that other studies have occurred or are underway.
“That said,” Beckett wrote in an emailed response to questions from MIT Technology Review, “it seems unreasonable that BioFiltro would be held to a standard of not being allowed to invest in technical research by qualified third parties to learn more about the capabilities of our technology, and use the results of that research to enter new markets and to understand the value we can bring to projects or entire industries beyond water treatment.”
BioFiltro is already building a business model around the available findings.
The company, founded in 2009, has been selling its vermifiltration systems or services to other industries around the world for years. It says there are around 225 operating in nine countries, at sites including municipal wastewater facilities, wineries, fruit processors, and other industrial operations.
But BioFiltro, whose US headquarters are in Davis, California, is seeing increasing demand among dairies as the industry faces growing pressure to address manure pollution. Late last year, it raised $35 million that the business says it will use, in large part, to accelerate its growth across the sector.
In an interview, Sarah Ploss, the company’s senior vice president of agriculture, explains the basic financial template for how it works with dairies: BioFiltro pays for, owns, installs, and operates the system. The farm, in turn, covers a share of the additional electricity, operations, and maintenance costs.
Ploss says the dairy gets back clean water and the ability to focus on what it does best: producing milk. For its part, BioFiltro can generate carbon credits from the reduction in greenhouse gases, which it can then sell to makers of consumer packaged goods that are looking for ways to address the emissions throughout their supply chains, she says.
BioFiltro says that Verra, which sets standards for and assesses greenhouse-gas crediting projects, has registered two of its projects: the Royal Dairy and Moxee Dairy, both in Washington.
The Swiss confectionary giant Nestlé has bought more than 150,000 credits generated by the Royal Dairy’s vermifiltration system, according to an offsets database managed by CarbonPlan, which assesses the scientific integrity of climate action programs. Ploss said that BioFiltro has sold more than 200,000 credits from the project so far, and adds that it secured a different buyer for a project in California, which she said she couldn’t name.

Three additional projects involving BioFiltro systems took the initial steps to become registered through Verra but didn’t move forward and weren’t built, Ploss said in an email. The request for registration for the Alberto Dairy estimates that the system there will reduce emissions by the equivalent of more than 30,000 metric tons of carbon dioxide per year.
BioFiltro could take advantage of another revenue source as well: selling what it calls vermicompost, a rich soil additive composed of the leftover materials in the biofilter, including worm castings—a combination of cocoons, excrement, and remains. At retail, worm castings can run more than $500 per ton.
Beckett says the company is still developing that market but notes that it could help the industry offset rising fertilizer costs.
“I think we’re going to enable a larger-scale use and adoption of it that could be meaningful to agriculture,” he says, adding: “These will become basically soil production facilities.”
Determining how well vermifiltration and other manure management approaches work will require more time and more research, experts say.
Katharine Dickson, an agricultural emissions scientist who recently finished a postdoctoral program at UC Davis, says there should be in-the-field accounting to ensure that any of these methods are working as well as hoped—or to the degree government policy programs assume. All of which is tricky to achieve given the dynamic biological processes playing out in live animals and microbial communities on open farms, she adds.
“Vermifiltration, for example, depends on a live earthworm population whose performance is sensitive to temperature, moisture, and toxicity, and can shift with seasonal conditions or changes in herd size and manure characteristics on a given farm,” Dickson said in an email.
The use of carbon credits to earn money from vermifiltration projects raises a different set of potential concerns. Most notably, if the methane decreases aren’t as significant as assumed, the projects could receive more credits than they deserve.
There are more complicated issues as well. For the carbon credit system to make any real difference in the net amount of greenhouse gas in the atmosphere, it must produce emissions reductions that wouldn’t have occurred without that financial incentive. If it was going to happen anyway—as a result, say, of rich grants, legal pressures, or looming policies—the buyer of the credits can’t legitimately claim to have made any progress on its own climate emissions, says Grayson Badgley, a research scientist at CarbonPlan.
On that point, if California agriculture doesn’t meet its looming methane reduction targets, the carrots the state offers could be replaced by sticks: The California Air Resources Board recently began discussing rules that would force, rather than nudge, the sector to meet the 40% reduction required under the 2016 law.
“If lots of dairies are cleaning up their act ahead of pending regulation, it really does seem like the regulation, not offsets, is driving that action,” Badgley wrote in an email. “Trying to collect as many offsets prior to that deadline might adhere to the rules of the market, while still raising questions about whether those rules have enabled real climate action.”
Beckett disagreed that the possibility of forthcoming regulations undermines the case for generating carbon credits from current projects.
“It’s true the state has net reduction targets that it hopes to meet, but it’s clear the state of California has favored market-based solutions and tried to provide some support via grant programs,” he wrote. “I’m on the science side of our business, not the business development side, but still think I can tell you with complete transparency that we would not have systems installed on [California] dairies without the sale of voluntary carbon credits.”
Ploss also stressed that the company goes through a careful “validation and verification process” on the farms to understand how much vermifiltration reduces greenhouse gases.
“We’ve got sensors and cameras and all sorts of stuff so that we can look into any of our systems, 24-7,” Ploss says. “We know through sampling. We know through what’s going through the system, what came out of the system. We know by all the measurements on any given month: What did that system do in terms of generating carbon credits?”
Agueda also disputes the critique.
“The installation of the vermifiltration system would not have occurred without the ability to generate carbon credits,” he said in an email. “The project required a substantial capital investment, and the anticipated carbon credit revenue was a key factor in making the investment financially feasible.”

California decided to incentivize vermifiltration, along with other approaches, because it can offer multiple benefits, including cleaner water, less nitrogen, and lower greenhouse-gas emissions, while also creating economic value from manure, wrote Roberta Franco, a senior environmental scientist at the California Department of Food and Agriculture, in an emailed response to questions from MIT Technology Review.
She added that the decision was based on a number of studies as well as the 2022 recommendations from a task force composed of scientists, technical experts, and others.
Even if California has made missteps, most notably in funneling too much money to anaerobic digesters at the expense of other methods, it’s created a test lab that’s achieved real progress and provided lessons that other regions can learn from.
One way or another, more parts of the world will need to set up similar programs, offering greater support or creating stricter rules, if we hope to really drive down the emissions from manure, says Maria Bowman, who leads the Agricultural Nitrogen Transformation Program at Spark Climate, a San Francisco nonprofit.
For his part, Agueda says that the vermifiltration system has offered a number of benefits to his family’s farm, at little additional cost to them. By cleaning up the water that cycles back through their flush and irrigation systems, the biofilter has reduced clogging, decreased odors, and improved the health of the herd.
He says that each generation modernizes dairy farming in its own way. His father and uncle, for instance, incorporated computers and data management systems into the daily operations of the Alberto Dairy. He believes it’s the responsibility of his generation to make a similar effort to reduce the pollution that’s long plagued the sector.
“We knew that in the next generation we have to invest in environmental sustainability,” he says. “We didn’t know if it was gonna work or not, but we’re very happy with how it’s turned out.”